PMC:7242013 / 5293-5440
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"180","span":{"begin":49,"end":57},"obj":"Species"},{"id":"221","span":{"begin":31,"end":36},"obj":"Disease"},{"id":"222","span":{"begin":67,"end":75},"obj":"Disease"}],"attributes":[{"id":"A180","pred":"tao:has_database_id","subj":"180","obj":"Tax:9606"},{"id":"A221","pred":"tao:has_database_id","subj":"221","obj":"MESH:C000657245"},{"id":"A222","pred":"tao:has_database_id","subj":"222","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"bidity risk factors for severe COVID‐19\nConsider patients with CLD/COVID‐19 for early admission and clinical trial\nUse acetaminophen (2–3 g/day is "}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T72","span":{"begin":31,"end":39},"obj":"Disease"},{"id":"T73","span":{"begin":63,"end":66},"obj":"Disease"},{"id":"T74","span":{"begin":67,"end":75},"obj":"Disease"}],"attributes":[{"id":"A72","pred":"mondo_id","subj":"T72","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A73","pred":"mondo_id","subj":"T73","obj":"http://purl.obolibrary.org/obo/MONDO_0008964"},{"id":"A74","pred":"mondo_id","subj":"T74","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"bidity risk factors for severe COVID‐19\nConsider patients with CLD/COVID‐19 for early admission and clinical trial\nUse acetaminophen (2–3 g/day is "}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T71","span":{"begin":40,"end":114},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"bidity risk factors for severe COVID‐19\nConsider patients with CLD/COVID‐19 for early admission and clinical trial\nUse acetaminophen (2–3 g/day is "}